Literature DB >> 1450674

Febrile infections and malignant melanoma: results of a case-control study.

K F Kölmel1, O Gefeller, B Haferkamp.   

Abstract

Several reports have described an inverse relationship between the frequency of infections and various malignancies. In this paper results of a hospital-based case control study on 139 melanoma patients and 271 suitable selected controls are presented, addressing the question of whether this relationship exists with respect to malignant melanoma while simultaneously controlling for the effects of other risk factors. Data on childhood diseases (group I), febrile diseases of adulthood (group II) and common febrile infections within a 5-year period prior to the diagnosis of melanoma (group III) were collected using a standardized interview. Group I diseases did not show a marked influence on the risk of malignant melanoma. Considering group II diseases, a significant protective effect was determined for chronic infectious diseases (OR = 0.32) and also for wound infections, abscesses and furunculosis (OR = 0.21). In group III, herpes simplex infections (OR = 0.45) and influenza/common cold (OR = 0.32) substantially reduced the melanoma risk. This effect was less pronounced for gastroenteritis (OR = 0.52). Analysis of the cumulative influence of infections pointed to a strong dose-response relationship between the frequency of febrile infections in adulthood and malignant melanoma. In particular, the risk reduction was striking when two or more febrile infections were compared to no febrile infections in group II (OR = 0.09) and group III (OR = 0.20). The study confirms the hypothesis that an inverse relationship exists between febrile infections and malignant melanoma, but these results have to be interpreted cautiously due to the inherent limitations of the case-control design.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1450674     DOI: 10.1097/00008390-199209000-00009

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  13 in total

1.  Childhood infectious disease and premature death from cancer: a prospective cohort study.

Authors:  Peter W G Tennant; Louise Parker; Julian E Thomas; Sir Alan W Craft; Mark S Pearce
Journal:  Eur J Epidemiol       Date:  2013-02-15       Impact factor: 8.082

2.  Cancer increased after a reduction of infections in the first half of this century in Italy: etiologic and preventive implications.

Authors:  G Mastrangelo; E Fadda; G Milan
Journal:  Eur J Epidemiol       Date:  1998-12       Impact factor: 8.082

3.  Is there a relationship between influenza vaccinations and risk of melanoma? A population-based case-control study.

Authors:  G Mastrangelo; C R Rossi; A Pfahlberg; V Marzia; A Barba; M Baldo; E Fadda; G Milan; K F Kölmel
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 12.434

4.  Joint effects of febrile acute infection and an interferon-γ polymorphism on breast cancer risk.

Authors:  Yi Su; Lu-Ying Tang; Li-Juan Chen; Jian-Rong He; Feng-Xi Su; Ying Lin; Wei-Qing Chen; Xiao-Ming Xie; Ze-Fang Ren
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

5.  Vaccinia scars associated with improved survival among adults in rural Guinea-Bissau.

Authors:  Mette Lundsby Jensen; Sangeeta Dave; Maarten Schim van der Loeff; Carlos da Costa; Tim Vincent; Aleksandra Leligdowicz; Christine Stabell Benn; Adam Roth; Henrik Ravn; Ida Maria Lisse; Hilton Whittle; Peter Aaby
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

Review 6.  Protecting the normal in order to better kill the cancer.

Authors:  Bingya Liu; Lewis Ezeogu; Lucas Zellmer; Baofa Yu; Ningzhi Xu; Dezhong Joshua Liao
Journal:  Cancer Med       Date:  2015-07-14       Impact factor: 4.452

Review 7.  The biography of the immune system and the control of cancer: from St Peregrine to contemporary vaccination strategies.

Authors:  Bernd Krone; Klaus F Kölmel; John M Grange
Journal:  BMC Cancer       Date:  2014-08-16       Impact factor: 4.430

8.  Human endogenous retroviruses and cancer prevention: evidence and prospects.

Authors:  Luca Cegolon; Cristiano Salata; Elisabete Weiderpass; Paolo Vineis; Giorgio Palù; Giuseppe Mastrangelo
Journal:  BMC Cancer       Date:  2013-01-03       Impact factor: 4.430

Review 9.  HERV-K(HML-2), the Best Preserved Family of HERVs: Endogenization, Expression, and Implications in Health and Disease.

Authors:  Oliver Hohn; Kirsten Hanke; Norbert Bannert
Journal:  Front Oncol       Date:  2013-09-20       Impact factor: 6.244

Review 10.  Fever in Cancer Treatment: Coley's Therapy and Epidemiologic Observations.

Authors:  Gunver S Kienle
Journal:  Glob Adv Health Med       Date:  2012-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.